data_1nra_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nra _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 3.9 pttt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.406 -0.59 . . . . 3.48 109.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.469 ' C ' ' CD ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -172.62 161.19 4.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 1.73 109.729 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CG ' ' CD2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -87.57 169.09 12.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.606 -0.887 . . . . 1.38 108.606 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 150.51 -168.45 30.37 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.013 -1.565 . . . . 0.8 110.788 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.594 ' CE1' HG13 ' A' ' 41' ' ' VAL . 97.9 m-85 -100.58 105.6 38.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.636 -0.92 . . . . 2.19 109.635 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 4' ' ' GLY . 2.3 Cg_endo -62.66 113.26 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.902 1.735 . . . . 0.6 110.234 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.51 ' HB ' ' N ' ' A' ' 12' ' ' CYS . 16.3 m -107.61 143.3 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 1.16 109.485 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -68.82 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 1.18 109.326 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 p -67.4 -22.99 65.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 1.64 109.593 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 11' ' ' ASN . . . -83.46 -5.19 88.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.945 -1.262 . . . . 0.82 109.945 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 23.6 t30 78.5 41.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 1.4 109.126 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.51 ' N ' ' HB ' ' A' ' 7' ' ' VAL . 14.1 m -114.65 112.34 22.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.175 -0.676 . . . . 1.09 109.175 -179.965 -46.394 -108.865 74.881 104.243 2.021 104.163 76.897 170.53 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -69.45 118.35 12.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 4.18 109.555 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 42' ' ' SER . 36.6 m-85 -49.71 137.74 15.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 2.29 109.315 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.59 -170.62 2.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 2.68 109.591 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.503 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 1.2 p -170.3 175.97 4.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 1.48 110.847 -179.866 36.18 93.357 85.564 104.501 2.021 104.772 73.984 -174.346 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 16' ' ' CYS . 4.0 mt -128.9 -34.49 1.93 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.93 -0.767 . . . . 2.49 108.93 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 2.4 mttp -120.61 -167.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 3.45 109.162 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 7.9 t0 -98.29 -26.99 14.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.995 . . . . 1.4 110.175 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -71.01 -27.57 63.78 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.06 -1.025 . . . . 1.79 109.874 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -68.94 -31.56 70.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 2.26 108.689 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 26' ' ' CYS . 67.0 m -77.83 -46.64 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.495 -0.753 . . . . 0.73 109.436 179.641 -72.432 -40.936 -100.495 105.406 2.021 105.814 -40.576 -103.434 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.43 -46.97 79.99 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.534 0.683 . . . . 1.64 109.25 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -63.59 -70.7 0.2 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.437 0.637 . . . . 1.34 109.328 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -46.37 -25.71 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 1.3 109.1 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.8 m -72.66 -46.13 55.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.424 -0.798 . . . . 0.64 109.473 -179.752 -89.812 -46.525 -98.999 105.707 2.02 105.0 -38.462 -68.919 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mt -54.8 -39.08 68.1 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.339 -0.851 . . . . 2.44 108.719 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.75 -33.6 75.98 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.43 -0.794 . . . . 2.41 108.923 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.544 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.3 2.15 11.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.692 -0.63 . . . . 3.13 110.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 83.48 10.8 0.48 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.688 -0.632 . . . . 2.26 110.058 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . . . -90.35 146.62 24.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.806 -1.184 . . . . 1.14 110.352 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.18 -52.2 37.14 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.548 0.69 . . . . 1.38 109.148 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 46' ' ' TYR . 1.1 ptpt -142.51 165.12 28.27 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.793 -0.763 . . . . 3.01 109.637 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' SG ' ' A' ' 26' ' ' CYS . . . -174.09 140.65 5.57 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.657 -1.259 . . . . 0.48 110.332 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 18.1 p90 -118.55 -169.0 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -1.025 . . . . 2.33 109.326 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 22' ' ' CYS . 48.7 t -110.45 101.88 10.55 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.731 -0.606 . . . . 0.89 110.226 -179.717 -174.346 73.984 85.564 104.772 2.021 104.501 93.357 36.18 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.474 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 51.6 t80 -76.39 92.77 3.4 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.429 -0.952 . . . . 2.64 108.429 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' O ' ' N ' ' A' ' 40' ' ' LYS . 4.6 m95 -64.84 -100.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.328 -0.857 . . . . 3.14 109.823 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' TRP . . . 40.34 29.1 0.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.026 -1.63 . . . . 1.75 109.026 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' TRP . 3.7 tttt 67.11 54.6 0.73 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.394 -1.062 . . . . 5.84 108.62 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.594 HG13 ' CE1' ' A' ' 5' ' ' TYR . 40.4 t -138.92 -104.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 4.18 110.453 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 41' ' ' VAL . 7.0 m -175.94 -167.25 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.802 -1.186 . . . . 1.75 109.978 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -61.32 -177.24 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.394 -0.816 . . . . 0.71 110.38 -179.717 -103.434 -40.576 -100.495 105.814 2.021 105.406 -40.936 -72.432 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 6.3 t80 -160.14 118.53 2.66 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.94 -0.763 . . . . 1.08 108.94 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.568 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 95.5 m -102.35 176.21 5.26 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.099 0.952 . . . . 0.4 110.154 -179.839 -68.919 -38.462 -98.999 105.0 2.02 105.707 -46.525 -89.812 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' CD2' ' CG ' ' A' ' 3' ' ' ASP . 59.5 m-85 -147.11 91.97 2.06 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.476 -1.305 . . . . 2.0 107.476 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.28 11.46 1.76 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.53 110.102 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.528 ' CD2' ' HB3' ' A' ' 29' ' ' ARG . 61.6 mt -58.96 158.23 17.64 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.299 . . . . 1.26 109.238 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.514 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 4.4 Cg_exo -60.05 152.41 65.39 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.06 1.84 . . . . 0.88 110.229 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.19 -62.05 1.91 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.236 -0.915 . . . . 1.57 109.384 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 52' ' ' SER . 10.6 p30 -67.56 -7.04 22.93 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.799 -0.563 . . . . 1.7 109.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.514 ' HB2' ' CD ' ' A' ' 49' ' ' PRO . 13.2 t -41.37 107.18 0.47 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 1.22 109.562 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' O ' HG23 ' A' ' 7' ' ' VAL . 4.5 Cg_exo -59.26 107.97 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.909 1.74 . . . . 0.98 110.362 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 7' ' ' VAL . 69.6 p -118.63 165.14 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 1.18 109.342 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 54' ' ' THR . 31.1 tptt -42.56 116.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 1.79 109.639 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 53.0 m -99.78 -94.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 2.09 109.599 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.2 p -142.76 61.02 1.43 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.375 -0.828 . . . . 2.84 109.535 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.87 -158.74 9.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 2.53 109.493 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -128.02 163.45 24.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -1.153 . . . . 5.12 109.554 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.4 t -70.71 88.34 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 1.66 109.428 -179.999 170.53 76.897 74.881 104.163 2.021 104.243 -108.865 -46.394 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.78 112.59 59.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 3.31 109.429 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.28 154.21 54.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.948 1.765 . . . . 3.49 110.325 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.964 -1.017 . . . . 4.78 109.492 179.981 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 3.9 pttt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.406 -0.59 . . . . 3.04 109.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.731 ' HE2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -172.62 161.19 4.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 1.02 109.729 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CG ' ' CD2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -87.57 169.09 12.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.606 -0.887 . . . . 1.38 108.606 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 150.51 -168.45 30.37 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.013 -1.565 . . . . 0.59 110.788 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 97.9 m-85 -100.58 105.6 38.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.636 -0.92 . . . . 1.31 109.635 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 2.3 Cg_endo -62.66 113.26 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.902 1.735 . . . . 0.55 110.234 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' PRO . 16.3 m -107.61 143.3 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.55 109.485 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -68.82 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 1.18 109.326 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 p -67.4 -22.99 65.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 1.29 109.593 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 11' ' ' ASN . . . -83.46 -5.19 88.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.945 -1.262 . . . . 0.74 109.945 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 23.6 t30 78.5 41.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 1.29 109.126 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.52 ' N ' ' HB ' ' A' ' 7' ' ' VAL . 14.1 m -114.65 112.34 22.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.175 -0.676 . . . . 1.09 109.175 -179.965 -46.394 -108.865 74.881 104.243 2.021 104.163 76.897 170.53 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -69.45 118.35 12.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 3.79 109.555 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 42' ' ' SER . 36.6 m-85 -49.71 137.74 15.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 1.39 109.315 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.59 -170.62 2.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 2.68 109.591 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 1.2 p -170.3 175.97 4.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 1.48 110.847 -179.866 36.18 93.357 85.564 104.501 2.021 104.772 73.984 -174.346 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 16' ' ' CYS . 4.0 mt -128.9 -34.49 1.93 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.93 -0.767 . . . . 2.07 108.93 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 2.4 mttp -120.61 -167.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 3.01 109.162 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 7.9 t0 -98.29 -26.99 14.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.995 . . . . 1.4 110.175 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -71.01 -27.57 63.78 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.06 -1.025 . . . . 1.79 109.874 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -68.94 -31.56 70.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 1.41 108.689 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 67.0 m -77.83 -46.64 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.495 -0.753 . . . . 0.7 109.436 179.641 -72.432 -40.936 -100.495 105.406 2.021 105.814 -40.576 -103.434 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.43 -46.97 79.99 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.534 0.683 . . . . 1.1 109.25 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -63.59 -70.7 0.2 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.437 0.637 . . . . 1.34 109.328 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -46.37 -25.71 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.63 109.1 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 1.8 m -72.66 -46.13 55.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.424 -0.798 . . . . 0.64 109.473 -179.752 -89.812 -46.525 -98.999 105.707 2.02 105.0 -38.462 -68.919 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mt -54.8 -39.08 68.1 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.339 -0.851 . . . . 1.94 108.719 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.75 -33.6 75.98 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.43 -0.794 . . . . 2.41 108.923 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.3 2.15 11.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.692 -0.63 . . . . 2.54 110.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 83.48 10.8 0.48 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.688 -0.632 . . . . 1.75 110.058 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . . . -90.35 146.62 24.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.806 -1.184 . . . . 0.53 110.352 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.18 -52.2 37.14 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.548 0.69 . . . . 1.38 109.148 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 46' ' ' TYR . 1.1 ptpt -142.51 165.12 28.27 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.793 -0.763 . . . . 2.55 109.637 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 26' ' ' CYS . . . -174.09 140.65 5.57 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.657 -1.259 . . . . 0.48 110.332 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 18.1 p90 -118.55 -169.0 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -1.025 . . . . 1.45 109.326 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 48.7 t -110.45 101.88 10.55 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.731 -0.606 . . . . 0.89 110.226 -179.717 -174.346 73.984 85.564 104.772 2.021 104.501 93.357 36.18 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 51.6 t80 -76.39 92.77 3.4 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.429 -0.952 . . . . 1.85 108.429 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' O ' ' N ' ' A' ' 40' ' ' LYS . 4.6 m95 -64.84 -100.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.328 -0.857 . . . . 2.7 109.823 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' TRP . . . 40.34 29.1 0.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.026 -1.63 . . . . 1.75 109.026 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' TRP . 3.7 tttt 67.11 54.6 0.73 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.394 -1.062 . . . . 5.52 108.62 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 40.4 t -138.92 -104.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 3.77 110.453 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 7.0 m -175.94 -167.25 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.802 -1.186 . . . . 1.28 109.978 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -61.32 -177.24 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.394 -0.816 . . . . 0.71 110.38 -179.717 -103.434 -40.576 -100.495 105.814 2.021 105.406 -40.936 -72.432 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 6.3 t80 -160.14 118.53 2.66 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.94 -0.763 . . . . 0.62 108.94 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 95.5 m -102.35 176.21 5.26 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.099 0.952 . . . . 0.4 110.154 -179.839 -68.919 -38.462 -98.999 105.0 2.02 105.707 -46.525 -89.812 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' CD2' ' CG ' ' A' ' 3' ' ' ASP . 59.5 m-85 -147.11 91.97 2.06 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.476 -1.305 . . . . 1.22 107.476 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.28 11.46 1.76 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.53 110.102 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 31' ' ' ALA . 61.6 mt -58.96 158.23 17.64 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.299 . . . . 0.63 109.238 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 4.4 Cg_exo -60.05 152.41 65.39 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.06 1.84 . . . . 0.77 110.229 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.19 -62.05 1.91 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.236 -0.915 . . . . 1.57 109.384 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 52' ' ' SER . 10.6 p30 -67.56 -7.04 22.93 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.799 -0.563 . . . . 1.53 109.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 54' ' ' THR . 13.2 t -41.37 107.18 0.47 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.84 109.562 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.5 Cg_exo -59.26 107.97 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.909 1.74 . . . . 0.88 110.362 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.731 HG21 ' HE2' ' A' ' 2' ' ' LYS . 69.6 p -118.63 165.14 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.67 109.342 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 54' ' ' THR . 31.1 tptt -42.56 116.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 1.14 109.639 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 57' ' ' SER . 53.0 m -99.78 -94.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 1.61 109.599 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 56' ' ' THR . 18.2 p -142.76 61.02 1.43 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.375 -0.828 . . . . 2.51 109.535 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.87 -158.74 9.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 2.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -128.02 163.45 24.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -1.153 . . . . 4.77 109.554 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.4 t -70.71 88.34 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 1.26 109.428 -179.999 170.53 76.897 74.881 104.163 2.021 104.243 -108.865 -46.394 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.78 112.59 59.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 2.82 109.429 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 Cg_exo -60.28 154.21 54.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.948 1.765 . . . . 3.04 110.325 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.964 -1.017 . . . . 4.6 109.492 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 48' ' ' LEU . 3.9 pttt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.406 -0.59 . . . . 3.04 109.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.731 ' HE2' HG21 ' A' ' 54' ' ' THR . 0.1 OUTLIER -172.62 161.19 4.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 1.02 109.729 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' CG ' ' CD2' ' A' ' 46' ' ' TYR . 0.8 OUTLIER -87.57 169.09 12.48 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.606 -0.887 . . . . 1.38 108.606 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 6' ' ' PRO . . . 150.51 -168.45 30.37 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.013 -1.565 . . . . 0.59 110.788 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 13' ' ' LYS . 97.9 m-85 -100.58 105.6 38.09 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.636 -0.92 . . . . 1.31 109.635 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 2.3 Cg_endo -62.66 113.26 1.89 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 121.902 1.735 . . . . 0.55 110.234 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 53' ' ' PRO . 16.3 m -107.61 143.3 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.55 109.485 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 38.1 p30 -68.82 -163.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.897 . . . . 1.18 109.326 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 p -67.4 -22.99 65.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 1.29 109.593 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 11' ' ' ASN . . . -83.46 -5.19 88.82 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.945 -1.262 . . . . 0.74 109.945 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 10' ' ' GLY . 23.6 t30 78.5 41.5 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -1.138 . . . . 1.29 109.126 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.52 ' N ' ' HB ' ' A' ' 7' ' ' VAL . 14.1 m -114.65 112.34 22.73 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.175 -0.676 . . . . 1.09 109.175 -179.965 -46.394 -108.865 74.881 104.243 2.021 104.163 76.897 170.53 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 5' ' ' TYR . 0.1 OUTLIER -69.45 118.35 12.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.204 -0.935 . . . . 3.79 109.555 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 42' ' ' SER . 36.6 m-85 -49.71 137.74 15.45 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.935 . . . . 1.39 109.315 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -92.59 -170.62 2.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.34 -0.85 . . . . 2.68 109.591 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.51 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 1.2 p -170.3 175.97 4.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -0.97 . . . . 1.48 110.847 -179.866 36.18 93.357 85.564 104.501 2.021 104.772 73.984 -174.346 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 16' ' ' CYS . 4.0 mt -128.9 -34.49 1.93 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.93 -0.767 . . . . 2.07 108.93 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 2.4 mttp -120.61 -167.09 1.41 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 3.01 109.162 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 19' ' ' ASP . 7.9 t0 -98.29 -26.99 14.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.109 -0.995 . . . . 1.4 110.175 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -71.01 -27.57 63.78 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.06 -1.025 . . . . 1.79 109.874 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -68.94 -31.56 70.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.124 -0.985 . . . . 1.41 108.689 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.489 ' O ' ' SG ' ' A' ' 26' ' ' CYS . 67.0 m -77.83 -46.64 20.91 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.495 -0.753 . . . . 0.7 109.436 179.641 -72.432 -40.936 -100.495 105.406 2.021 105.814 -40.576 -103.434 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -56.43 -46.97 79.99 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.534 0.683 . . . . 1.1 109.25 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -63.59 -70.7 0.2 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.437 0.637 . . . . 1.34 109.328 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -46.37 -25.71 0.7 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.396 -0.815 . . . . 0.63 109.1 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 34' ' ' GLY . 1.8 m -72.66 -46.13 55.43 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.424 -0.798 . . . . 0.64 109.473 -179.752 -89.812 -46.525 -98.999 105.707 2.02 105.0 -38.462 -68.919 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.1 mt -54.8 -39.08 68.1 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.339 -0.851 . . . . 1.94 108.719 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -66.75 -33.6 75.98 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.43 -0.794 . . . . 2.41 108.923 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' O ' ' HB3' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -75.3 2.15 11.87 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.692 -0.63 . . . . 2.54 110.118 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.563 ' HB3' ' O ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER 83.48 10.8 0.48 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.688 -0.632 . . . . 1.75 110.058 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.577 ' CB ' ' HB3' ' A' ' 45' ' ' CYS . . . -90.35 146.62 24.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.806 -1.184 . . . . 0.53 110.352 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -68.18 -52.2 37.14 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.548 0.69 . . . . 1.38 109.148 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.489 ' HG3' ' HB2' ' A' ' 46' ' ' TYR . 1.1 ptpt -142.51 165.12 28.27 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.793 -0.763 . . . . 2.55 109.637 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 26' ' ' CYS . . . -174.09 140.65 5.57 Favored Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.657 -1.259 . . . . 0.48 110.332 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.465 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 18.1 p90 -118.55 -169.0 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -1.025 . . . . 1.45 109.326 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' LYS . 48.7 t -110.45 101.88 10.55 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.731 -0.606 . . . . 0.89 110.226 -179.717 -174.346 73.984 85.564 104.772 2.021 104.501 93.357 36.18 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.484 ' O ' ' HB ' ' A' ' 41' ' ' VAL . 51.6 t80 -76.39 92.77 3.4 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.429 -0.952 . . . . 1.85 108.429 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.47 ' O ' ' N ' ' A' ' 40' ' ' LYS . 4.6 m95 -64.84 -100.87 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.328 -0.857 . . . . 2.7 109.823 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 38' ' ' TRP . . . 40.34 29.1 0.21 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.026 -1.63 . . . . 1.75 109.026 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 38' ' ' TRP . 3.7 tttt 67.11 54.6 0.73 Allowed 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.394 -1.062 . . . . 5.52 108.62 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 40.4 t -138.92 -104.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 3.77 110.453 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.432 ' HB3' ' O ' ' A' ' 14' ' ' TYR . 7.0 m -175.94 -167.25 0.22 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.802 -1.186 . . . . 1.28 109.978 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -61.32 -177.24 0.09 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.394 -0.816 . . . . 0.71 110.38 -179.717 -103.434 -40.576 -100.495 105.814 2.021 105.406 -40.936 -72.432 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.471 ' O ' ' CA ' ' A' ' 34' ' ' GLY . 6.3 t80 -160.14 118.53 2.66 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.94 -0.763 . . . . 0.62 108.94 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.577 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 95.5 m -102.35 176.21 5.26 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 122.099 0.952 . . . . 0.4 110.154 -179.839 -68.919 -38.462 -98.999 105.0 2.02 105.707 -46.525 -89.812 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.543 ' CD2' ' CG ' ' A' ' 3' ' ' ASP . 59.5 m-85 -147.11 91.97 2.06 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.476 -1.305 . . . . 1.22 107.476 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.28 11.46 1.76 Allowed Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.102 -1.199 . . . . 0.53 110.102 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.55 HD23 ' HB2' ' A' ' 31' ' ' ALA . 61.6 mt -58.96 158.23 17.64 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.991 -1.299 . . . . 0.63 109.238 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' CD ' ' HB2' ' A' ' 52' ' ' SER . 4.4 Cg_exo -60.05 152.41 65.39 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.06 1.84 . . . . 0.77 110.229 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.19 -62.05 1.91 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.236 -0.915 . . . . 1.57 109.384 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 52' ' ' SER . 10.6 p30 -67.56 -7.04 22.93 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.799 -0.563 . . . . 1.53 109.981 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.598 ' O ' HG23 ' A' ' 54' ' ' THR . 13.2 t -41.37 107.18 0.47 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.84 109.562 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.726 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.5 Cg_exo -59.26 107.97 0.4 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.909 1.74 . . . . 0.88 110.362 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.731 HG21 ' HE2' ' A' ' 2' ' ' LYS . 69.6 p -118.63 165.14 14.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.311 -0.868 . . . . 0.67 109.342 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 54' ' ' THR . 31.1 tptt -42.56 116.49 0.86 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.837 . . . . 1.14 109.639 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.53 HG22 ' N ' ' A' ' 57' ' ' SER . 53.0 m -99.78 -94.99 0.25 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 1.61 109.599 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.53 ' N ' HG22 ' A' ' 56' ' ' THR . 18.2 p -142.76 61.02 1.43 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.375 -0.828 . . . . 2.51 109.535 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.87 -158.74 9.35 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.493 -1.443 . . . . 2.0 109.493 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -128.02 163.45 24.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -1.153 . . . . 4.77 109.554 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' CYS . . . . . . . . . . . . . 16.4 t -70.71 88.34 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 1.26 109.428 -179.999 170.53 76.897 74.881 104.163 2.021 104.243 -108.865 -46.394 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -95.78 112.59 59.73 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.91 . . . . 2.82 109.429 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.567 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 3.4 Cg_exo -60.28 154.21 54.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 121.948 1.765 . . . . 3.04 110.325 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 62' ' ' PRO . . . . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.964 -1.017 . . . . 4.6 109.492 179.981 . . . . . . . . 1 1 . 1 stop_ save_